These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38711969)

  • 1. Antimicrobial efficacy of
    Scaglione E; Sateriale D; Mantova G; Di Rosario M; Continisio L; Vitiello M; Pagliarulo C; Colicchio R; Pagliuca C; Salvatore P
    Front Microbiol; 2024; 15():1383027. PubMed ID: 38711969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pomegranate peel extract is an effective agent against MDR bacteria.
    Alqahtani A; Mohamed AA; Ahmad I; Alraey Y; Asiri M; Kopel J; Alshahrani MM
    Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):6-11. PubMed ID: 37571908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital.
    Pandey R; Mishra SK; Shrestha A
    Infect Drug Resist; 2021; 14():2201-2212. PubMed ID: 34163185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal efficacy of atmospheric pressure non-thermal plasma (APNTP) against the ESKAPE pathogens.
    Flynn PB; Higginbotham S; Alshraiedeh NH; Gorman SP; Graham WG; Gilmore BF
    Int J Antimicrob Agents; 2015 Jul; 46(1):101-7. PubMed ID: 25963338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial, Antibiofilm, and Antioxidant Properties of
    Garcia J; Rodrigues F; Castro F; Aires A; Marques G; Saavedra MJ
    Front Nutr; 2021; 8():773346. PubMed ID: 35281762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.
    Mulani MS; Kamble EE; Kumkar SN; Tawre MS; Pardesi KR
    Front Microbiol; 2019; 10():539. PubMed ID: 30988669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PlyKp104, a Novel Phage Lysin for the Treatment of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Other Gram-Negative ESKAPE Pathogens.
    Euler CW; Raz A; Hernandez A; Serrano A; Xu S; Andersson M; Zou G; Zhang Y; Fischetti VA; Li J
    Antimicrob Agents Chemother; 2023 May; 67(5):e0151922. PubMed ID: 37098944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel silver nanoparticle-antibiotic combinations as promising antibacterial and anti-biofilm candidates against multiple-antibiotic resistant ESKAPE microorganisms.
    Mishra M; Ballal A; Rath D; Rath A
    Colloids Surf B Biointerfaces; 2024 Apr; 236():113826. PubMed ID: 38447448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternatives for the treatment of infections caused by ESKAPE pathogens.
    da Rosa TF; Coelho SS; Foletto VS; Bottega A; Serafin MB; Machado CS; Franco LN; de Paula BR; Hörner R
    J Clin Pharm Ther; 2020 Aug; 45(4):863-873. PubMed ID: 32339305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcus aureus/Staphylococcus epidermidis from skin microbiota are balanced by Pomegranate peel extract: An eco-sustainable approach.
    D'Arcangelo S; Di Fermo P; Diban F; Ferrone V; D'Ercole S; Di Giulio M; Di Lodovico S
    PLoS One; 2024; 19(8):e0308211. PubMed ID: 39088519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Punica granatum peel extracts: HPLC fractionation and LC MS analysis to quest compounds having activity against multidrug resistant bacteria.
    Khan I; Rahman H; Abd El-Salam NM; Tawab A; Hussain A; Khan TA; Khan UA; Qasim M; Adnan M; Azizullah A; Murad W; Jalal A; Muhammad N; Ullah R
    BMC Complement Altern Med; 2017 May; 17(1):247. PubMed ID: 28468660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial Efficiency of
    Roman H; Niculescu AG; Lazăr V; Mitache MM
    Antibiotics (Basel); 2023 Nov; 12(11):. PubMed ID: 37998837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Pi H; Nguyen HT; Venter H; Boileau AR; Woolford L; Garg S; Page SW; Russell CC; Baker JR; McCluskey A; O'Donovan LA; Trott DJ; Ogunniyi AD
    Front Microbiol; 2020; 11():1556. PubMed ID: 32849325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial potential of the Mayan medicine plant Matayba oppositifolia (A. Rich.) Britton against antibiotic-resistant priority pathogens.
    de Jesús Dzul-Beh A; Uc-Cachón AH; González-Sánchez AA; Dzib-Baak HE; Ortiz-Andrade R; Barrios-García HB; Jiménez-Delgadillo B; Molina-Salinas GM
    J Ethnopharmacol; 2023 Jan; 300():115738. PubMed ID: 36165961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of medicinal plants against ESKAPE: An update.
    Bhatia P; Sharma A; George AJ; Anvitha D; Kumar P; Dwivedi VP; Chandra NS
    Heliyon; 2021 Feb; 7(2):e06310. PubMed ID: 33718642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validated Preclinical Mouse Model for Therapeutic Testing against Multidrug-Resistant Pseudomonas aeruginosa Strains.
    Warawa JM; Duan X; Anderson CD; Sotsky JB; Cramer DE; Pfeffer TL; Guo H; Adcock S; Lepak AJ; Andes DR; Slone SA; Stromberg AJ; Gabbard JD; Severson WE; Lawrenz MB
    Microbiol Spectr; 2022 Oct; 10(5):e0269322. PubMed ID: 36094219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the antimicrobial activity of silver nanoparticles against ESKAPE bacteria and emerging fungal pathogens by using tea extracts.
    Raza S; Wdowiak M; Grotek M; Adamkiewicz W; Nikiforow K; Mente P; Paczesny J
    Nanoscale Adv; 2023 Oct; 5(21):5786-5798. PubMed ID: 37881701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Antibiotic Resistance of ESKAPE Pathogens Over Five Years in an Infectious Diseases Hospital from South-East of Romania.
    Arbune M; Gurau G; Niculet E; Iancu AV; Lupasteanu G; Fotea S; Vasile MC; Tatu AL
    Infect Drug Resist; 2021; 14():2369-2378. PubMed ID: 34194233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.